Damora Therapeutics, Inc.
DMRA
$31.04
$0.311.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5,193.46% | 4,363.51% | 1,717.45% | -61.35% | -55.34% |
| Total Receivables | -10.93% | -2.51% | 2.04% | -17.68% | -42.59% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.74% | -0.73% | -2.20% | -37.08% | -22.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.18% | -27.15% | 10.90% | 449.51% | 461.97% |
| Total Current Assets | 4,072.78% | 3,487.80% | 1,446.55% | -53.79% | -48.24% |
|
|
|||||
| Total Current Assets | 4,072.78% | 3,487.80% | 1,446.55% | -53.79% | -48.24% |
| Net Property, Plant & Equipment | -- | -- | -20.00% | 20.21% | -14.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -91.14% | -89.27% | -- | -60.22% | -72.71% |
| Total Assets | 3,870.75% | 3,384.82% | 1,420.70% | -54.07% | -49.84% |
|
|
|||||
| Total Accounts Payable | 360.58% | 131.36% | 4,585.68% | 3.38% | 4.42% |
| Total Accrued Expenses | 839.06% | 497.93% | 123.99% | 62.50% | 2.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 25.00% | -53.13% | -80.52% |
| Total Finance Division Other Current Liabilities | 2,354.00% | 3,964.92% | 242.30% | -56.24% | -71.36% |
| Total Other Current Liabilities | 2,354.00% | 3,964.92% | 242.30% | -56.24% | -71.36% |
| Total Current Liabilities | 947.93% | 1,435.27% | 1,576.36% | 7.46% | -29.12% |
|
|
|||||
| Total Current Liabilities | 947.93% | 1,435.27% | 1,576.36% | 7.46% | -29.12% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -13.11% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -44.90% | -40.00% | -34.88% | -- | -- |
| Total Liabilities | 907.20% | 1,339.55% | 1,448.58% | 11.80% | -26.18% |
|
|
|||||
| Common Stock & APIC | 218.73% | 205.90% | 6.44% | 0.49% | 0.69% |
| Retained Earnings | -92.71% | -83.94% | -75.61% | -5.85% | -6.22% |
| Treasury Stock & Other | -9.52% | 151.33% | 726.80% | 23.76% | 310.66% |
| Total Common Equity | 3,916.46% | 2,970.30% | -1,315.35% | -68.16% | -59.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 9,594.03% | 9,639.12% | 30,506.84% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 9,594.03% | 9,639.12% | 30,506.84% | -- | -- |
|
|
|||||
| Total Common Equity | 3,916.46% | 2,970.30% | -1,315.35% | -68.16% | -59.25% |
| Total Preferred Equity | 9,594.03% | 9,639.12% | 30,506.84% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4,611.58% | 3,631.88% | 1,418.41% | -61.75% | -53.57% |
|
|
|||||